Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Lauriola

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
ACS Medicinal Chemistry Letters|February 14, 2024
Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2Deborah Grifagni, Elena Lenci, Alessia De Santis, et al.
Frontiers in Pharmacology|June 6, 2018
Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian CancerLeda Severi, Lorena Losi, Sergio Fonda, et al.
Molecular Cell|October 30, 2025
The E3 ligase RNF32 controls the IκB kinase complex and NF-κB signaling in intestinal stem cellsAngela Lauriola, Juliana Haydeé Enriqué Steinberg, Motoharu Sarubo, et al.
Elife|December 7, 2022
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growthLuca Costantino, Stefania Ferrari, Matteo Santucci, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
ACS Medicinal Chemistry Letters|February 14, 2024
Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2Deborah Grifagni, Elena Lenci, Alessia De Santis, et al.
Frontiers in Pharmacology|June 6, 2018
Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian CancerLeda Severi, Lorena Losi, Sergio Fonda, et al.
Molecular Cell|October 30, 2025
The E3 ligase RNF32 controls the IκB kinase complex and NF-κB signaling in intestinal stem cellsAngela Lauriola, Juliana Haydeé Enriqué Steinberg, Motoharu Sarubo, et al.
Elife|December 7, 2022
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growthLuca Costantino, Stefania Ferrari, Matteo Santucci, et al.
Pageof 3